Thioridazine: A Potential Adjuvant in Pharmacotherapy of Drug Resistant Tuberculosis

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20141207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Adjuvant Interferon Gamma in Patients With Drug – Resistant Pulmonary Tuberculosis: A Pilot Study

BMC Infectious Diseases
Infectious Diseases
2004English

Drug-Resistant Tuberculosis

Drug and Therapeutics Bulletin
MedicinePharmacology
1995English

Encouraging Drug-Resistant Tuberculosis

BMJ
1953English

Belarus and Drug-Resistant Tuberculosis

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2019English

Transmission of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in a Metropolitan City

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Extensively Drug-Resistant Tuberculosis in South Africa

The Lancet
Medicine
2010English

Prevalence of Multi Drug Resistant Tuberculosis Among Presumptive Multi Drug Resistant Tuberculosis Cases in Amhara National Regional State, Ethiopia

Mycobacterial Diseases
2014English

Increasing Drug Resistant Tuberculosis in the UK

BMJ
2008English

Multidrug and Extensively Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy